Greif stock has delivered a 54.1% return over the past 5 years, yet its current valuation screens as somewhat rich on market multiples and only middling on the broader checks. This raises the question of how much optimism is already in the price.

• A 54.1% 5 year return suggests Greif has rewarded patient shareholders, so investors now need to judge whether that strength is already reflected in the share price.
• Expectations around Greif's ability to sustain cash generation from its packaging operations can support the current valuation, while any pressure on margins or higher capital needs may limit how much room there is for further rerating.
• With a value score of 3 out of 6, Greif offers a mixed picture rather than a clear bargain or obvious overvaluation on the broader set of valuation checks.

The stock's next move may depend on whether Greif's current price already fully reflects those 5 year gains and the market's expectations for its cash flows and risk profile.

Is Greif Getting Expensive on Earnings?

The P/E ratio is a useful yardstick for Greif because earnings are a key driver for mature packaging businesses. Greif currently trades on a P/E of about 19.5x, which sits above the Packaging industry average of roughly 16.0x and below the wider peer group at about 37.2x. That places the stock at a modest premium to its closest industry cohort, even if it does not look stretched versus some broader comparables.

The tailored fair P/E ratio for Greif is estimated at around 17.0x, which implies the current 19.5x level is somewhat rich relative to what would be expected given its profile and risks. For you as a shareholder or prospective buyer, this suggests the market is already paying up for Greif and is assigning a higher price to each dollar of earnings than the model would indicate.

On this P/E yardstick, Greif stock currently screens as overvalued.

The Greif Narrative: What Would Justify Today's Price?

Simply Wall St Narratives for Greif sit between the current valuation puzzle and the assumptions that might justify a higher or lower share price, by spelling out what would need to happen to the company's future growth, margins and earnings for those scenarios to hold. Instead of leaving you with a single output from a ratio or model, they unpack the future that number relies on so you can later judge whether Greif's actual progress matches it, all within the Community page.

Community views on Greif sit far apart, with one camp leaning into the margin story while the other worries about how much is already priced in.

Bull case: 15% undervalued

"Analyst consensus highlights the $100 million cost optimization as margin accretive, but given the accelerated progress, the deployment of over 70 optimization work streams, and execution, Greif is positioned to substantially outperform consensus expectations on both net margin expansion and EBITDA growth..."

Bear case: 12% overvalued

"Management is leaning heavily on structural cost optimization, including a run rate target of $80 million to $90 million and a 10% professional headcount reduction, and once these savings roll through the P&L, the scope for further easy efficiencies shrinks, which could cap future margin gains and leave EBITDA growth more exposed if volumes do not recover..."

Do you think there's more to the story for Greif? Head over to our Community to see what others are saying!

The Bottom Line

Greif screens as overvalued on its current market multiples, so the market is already paying a full price for its earnings profile. With broader checks pointing to a mixed picture rather than a clear bargain, the stock no longer looks obviously cheap. From here, the real swing factor is whether Greif can sustain and expand margins enough to make the current P/E look reasonable, or whether earnings delivery and cash generation fall short of what the current valuation implies.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.